Chester County News and Community Website
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) today announced the pricing of its underwritten public offering of 8,000,000 shares of common stock at $2.25 per share. The offering is expected …
Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has revealed plans to conduct an underwritten public offering of common stock and warrants. The company will sell all offered securities directly, with …
Annovis Bio Announces Public Offering of Common Stock and Warrants Read More
MALVERN, PA — In a notable show of confidence, Cantaloupe, Inc. (Nasdaq: CTLP) has announced that its Chairman of the Board, Douglas Bergeron, and CEO, Ravi Venkatesan, have increased their stakes …
Cantaloupe, Inc. Executives Boost Confidence with Significant Stock Purchases Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced definitive agreements this week for the issuance and sale of 444,000 shares of common stock and warrants to purchase an additional …
NEXGEL Announces Direct Offering and Strategic Acquisition to Fuel Growth Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) have announced a definitive arrangement, wherein Neuronetics will acquire all outstanding common shares of Greenbrook in an …
Neuronetics Acquires Greenbrook TMS, Enhancing Mental Health Care Delivery Read More
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced the successful closing of its public offering of 30,434,783 shares of common stock on Friday. Each share was sold at $1.15, generating …
Ocugen Closes $35 Million Public Offering on Friday Read More MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) launched a public offering of its common stock on July 31, 2024. The company also plans to grant the underwriter a 30-day option …
Ocugen Announces Public Offering of Common Stock Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) recently revealed a novel approach to shareholder incentives by declaring a dividend of Series C Preferred Stock. For every share of common stock …
Ocugen Announces Unique Dividend Strategy with Series C Preferred Stock Read More
PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals Inc. (NASDAQ: INO) has announced the recent award of equity grants to two new employees as part of its 2022 Inducement Plan. The company’s …
INOVIO Awards Equity Grants to New Employees Under 2022 Inducement Plan Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) today unveiled a strategic move to safeguard its stockholders by adopting a limited duration stockholder rights agreement, commonly referred to as a …
Galera Therapeutics Implements Stockholder Rights Plan to Shield Investor Interests Read More